Tag: Patisiran

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Patisiran

Alnylam getting a rare kind of leader - The Boston Globe

Added to Collection on: 2021-11-28 21:07:15

Tags for this article:

Life Sciences
Health care
Health sciences
Alnylam Pharmaceuticals
Therapeutic gene modulation
RNA interference
Patisiran
GlaxoSmithKline
John Maraganore
Pfizer
Pharmaceutical industry
Novartis
Emma Greenstreet
Alnylam

Click the tags to see associated articles and topics

View Article Details
AstraZeneca and Ionis sign $3.6bn deal for eplontersen - PMLiVE

Added to Collection on: 2021-12-08 12:22:28

Tags for this article:

Branches of biology
Orphan drugs
Life Sciences
Biology
Amyloidosis
Antisense RNA
Therapeutic gene modulation
Neurological disorders
Familial amyloid polyneuropathy
Ionis Pharmaceuticals
Patisiran
Alnylam Pharmaceuticals
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca picks up new weapon in rare disease fight with Alnylam and Pfizer, paying $30 ...

Added to Collection on: 2022-01-07 18:33:32

Tags for this article:

Life Sciences
Health care
Health sciences
Alnylam Pharmaceuticals
Therapeutic gene modulation
RNA interference
Orphan drugs
AstraZeneca
Oxford–AstraZeneca COVID-19 vaccine
Amyloidosis
Patisiran

Click the tags to see associated articles and topics

View Article Details
Alnylam, awaiting key study data, builds case for its next rare disease drug | BioPharma Dive

Added to Collection on: 2022-01-21 17:21:21

Tags for this article:

Life Sciences
Health sciences
Health care
Orphan drugs
RNA interference
Alnylam Pharmaceuticals
Therapeutic gene modulation
Amyloidosis
Patisiran
Ionis Pharmaceuticals
Transthyretin
Familial amyloid polyneuropathy

Click the tags to see associated articles and topics

View Article Details
Alnylam (ALNY) Misses on Q1 Earnings, Lowers '22 Revenue View - April 29, 2022 - Zacks

Added to Collection on: 2022-04-29 16:44:02

Tags for this article:

Life Sciences
Health sciences
Health care
RNA interference
Orphan drugs
Alnylam Pharmaceuticals
Therapeutic gene modulation
Patisiran
Lumasiran
Small interfering RNA
Regeneron Pharmaceuticals
Novartis
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Alnylam follows rivals with new study results for kidney disease drug - BioPharma Dive

Added to Collection on: 2022-06-09 16:25:59

Tags for this article:

Kidney diseases
Health care
Life Sciences
Medicine
RNA interference
Alnylam Pharmaceuticals
Therapeutic gene modulation
Orphan drugs
Patisiran
IgA nephropathy
Kidney disease
Atrasentan

Click the tags to see associated articles and topics

View Article Details
Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape - TheStreet

Added to Collection on: 2022-07-01 17:34:07

Tags for this article:

Branches of biology
Life Sciences
Nucleic acids
RNA
Amyloidosis
Biotechnology
Molecular genetics
Alnylam Pharmaceuticals
RNA interference
Patisiran
Familial amyloid polyneuropathy
Intellia Therapeutics
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Alnylam drug succeeds in key heart disease study, boosting company | BioPharma Dive

Added to Collection on: 2022-08-03 11:44:28

Tags for this article:

Health sciences
Health
Life Sciences
Clinical research
RNA interference
Alnylam Pharmaceuticals
Therapeutic gene modulation
Design of experiments
Patisiran
Placebo
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Alnylam details anticipated results from heart disease drug trial - BioPharma Dive

Added to Collection on: 2022-09-08 07:51:08

Tags for this article:

Health
Branches of biology
Medicine
Alnylam Pharmaceuticals
Therapeutic gene modulation
Clinical research
Neurological disorders
Patisiran
Familial amyloid polyneuropathy
Transthyretin
Placebo
Amyloidosis

Click the tags to see associated articles and topics

View Article Details
Alnylam (ALNY) Q4 Loss Narrower Than Expected, Stock Dips 10% - February 16, 2024

Added to Collection on: 2024-02-16 17:03:48

Tags for this article:

Small interfering RNA
Orphan drugs
RNA
Therapeutic gene modulation
Alnylam Pharmaceuticals
Molecular genetics
Patisiran
RNA interference
Familial amyloid polyneuropathy
Amyloidosis
Vutrisiran
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details